Quick Takeaways
- Cormorant Asset Management, LP filed SCHEDULE 13G/A for EyePoint Pharmaceuticals, Inc. Common Stock (EYPT).
- Disclosed ownership: 10%.
- Date of event: 04 Dec 2025.
Cormorant Asset Management, LP - 04 Dec 2025 SCHEDULE 13G/A Report for EyePoint Pharmaceuticals, Inc. Common Stock (EYPT)
- Filing Manager
- Cormorant Asset Management, LP
- Reporting Manager
- Cormorant Asset Management, LP
- Symbol
- EYPT
- Shares outstanding
- 82,815,631 shares
- Disclosed Ownership
- 8,265,000 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G/A
- Filing time
- 08 Dec 2025, 16:06:44 UTC
- Date of event
- 04 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Cormorant Asset Management, LP disclosed 10% ownership in EyePoint Pharmaceuticals, Inc. Common Stock (EYPT) on 04 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 08 Dec 2025, 16:06.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 10% | 8,265,000 | 0 | 8,265,000 | /s/ Bihua Chen | Bihua Chen, Managing Member | |
| Chen Bihua | 10% | 8,265,000 | 0 | 8,265,000 | /s/ Bihua Chen | Bihua Chen |